HOME >> MEDICINE >> NEWS
K-State professor takes chemistry to another world

MANHATTAN, KAN. -- Astronaut health is one of NASA's top priorities.

Once beyond Earth's atmosphere, astronauts are exposed to ionizing radiation and microgravity. Effects from these, along with the potential buildup of toxins in the enclosed environment of a spaceship, put astronaut health at risk.

Kansas State University professor Chris Culbertson has been working with NASA to investigate how such hazardous conditions affect humans at the cellular level and how to lessen such conditions, thus allowing astronauts to work in a healthier environment.

Culbertson, an assistant professor of chemistry, is an expert in microfluidics, a branch of analytical chemistry that is focused on miniaturizing chemical analysis instrumentation. To demonstrate the capability of microfluidics, Culbertson uses a variety of devices for performing complex chemical analyses.

"Essentially, a microfluidic device is just a small piece of glass with channels etched in it," Culbertson said. "Those channels are smaller in diameter than that of a human hair. We can move chemicals through these channels to either separate them or we can use them to perform chemical reactions. Specifically for NASA, we are developing microfluidic devices which will allow us to automatically monitor the health of human cells on orbit."

In the past, astronauts have had to freeze cells and bring them back to earth for analysis. With Culbertson's device, the astronauts can look at DNA mutation rates in cells and how they change over time on orbit. Because of its compact size, the device is ideal for shuttle missions. Culbertson said it is also cost efficient because it does not require much power to operate.

To test the microfluidic devices, Culbertson and Greg Roman, graduate student in chemistry, have taken several flights on NASA's microgravity research aircraft.

"The 'vomit comet' is essentially an aircraft that does a series of parabolic maneuvers," Culber
'"/>

Contact: Chris Culbertson
culbert@k-state.edu
785-532-6685
Kansas State University
25-Apr-2005


Page: 1 2

Related medicine news :

1. K-State researcher working on a way to make snack foods with extra fiber
2. K-State National Agricultural Biosecurity Center director speaker at AAAS Biosecurity Symposium
3. K-State professors study risk attitudes and consequences of college drinking
4. K-States Culbertson receives $530,000 National Science Foundation award
5. K-State researchers designing better drug to treat cystic fibrosis
6. K-State researcher discovers compliments go a long way to improve body self-image in women
7. Rutgers professor Bart Krekelberg is named 1 of 20 US Pew Scholars for 2007
8. USC law professor battles schizophrenia
9. Decorated professor adds Farfel Award to his long list of honors
10. Honor for University of Nottingham professor
11. Carnegie Mellon professors question advice for nuclear attacks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: State professor takes chemistry another world

(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 ... Care, ScripNet and Procura Management, today announced that ... Award at Catamaran’s client advisory meeting. Conferred ... has partnered with Catamaran to create cutting edge ... This year, Healthcare Solutions was recognized for its ...
(Date:5/21/2013)... May 21, 2013 Two-thirds of patients ... cell lung cancer reported that they engage in at ... use, according to new findings from the National ... Kantar Health . The research will be presented today ... Society for Pharmacoeconomics and Outcomes Research) in New Orleans. ...
(Date:5/21/2013)... 2013 A plastic surgery Internet ... plastic surgery SEO services following an Internet survey. ... name the “Best Plastic Surgery SEO Services”. , ... was predictable. Well-known in the plastic surgery Internet ... than any other selection based on superior client ...
(Date:5/21/2013)... May 21, 2013 It’s nearly summer and ... camp or starting practice for summer or fall sports. ... or sporting activities can begin. , To help parents ... for youth sports or camp physicals at just ... will review a child’s medical history, perform a physical exam ...
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance Sales Representatives and ... Cabos, Mexico, Feb. 23-March 1, 2013, to help renovate Casa ... facility serves meals and provides a social outlet for 45 ... Platinum Vice President, Mike Muench, says that the idea for ... “Platinum got its start selling long-term care insurance ,” ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3
(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...
(Date:5/21/2013)... , May 21, 2013  Janssen R&D Ireland ... from the global Phase 3 PROMISE study demonstrating ... (TMC435) led to sustained virologic response 12 weeks ... percent of treatment-experienced genotype 1 chronic hepatitis C ... stages of liver fibrosis, when administered once daily ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Reimbursement Scenario for Medical Devices in ...   Changing Regulatory ... the US Market   ...
Breaking Medicine Technology:BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4
Cached News: